Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/25/2007WO2007118691A1 Lysobactin amides
10/25/2007WO2007118680A2 Remedies for ischemia
10/25/2007WO2007118431A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection
10/25/2007WO2007118423A1 Human recombinant erytheropoietin fusion proteins, preparing methods and uses thereof
10/25/2007WO2007118270A1 Cyclised alpha-conotoxin peptides
10/25/2007WO2007096142A3 Vascular tumor markers
10/25/2007WO2007091240A3 Treatment of immunological diseases
10/25/2007WO2007084342A3 Codon optimi zed il- 15 and il- 15r-alpha genes for expression in mammalian cells
10/25/2007WO2007050121A3 Site specific pegylated hemoglobin, method of preparing same, and uses thereof
10/25/2007WO2007035782A3 Protein kinase c peptide modulators of angiogenesis
10/25/2007WO2007018607A8 Therapeutic uses of artificial nanostructures
10/25/2007WO2007002285A3 Methods for treating neurological and psychiatric conditions
10/25/2007WO2006133145A3 Tat-007 and methods of assessing and treating cancer
10/25/2007WO2006105998A3 Treatment of cognitive and learning impairment
10/25/2007WO2006076254A3 Method of treating or preventing respiratory microbial infection of respiratory tissue
10/25/2007WO2006062776A3 Hydroxyapatite-binding peptides for bone growth and inhibition
10/25/2007WO2006023827A3 Methods for treatment of angiogenesis
10/25/2007WO2005081897A3 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber
10/25/2007WO2005034877A3 G-csf transferrin fusion proteins
10/25/2007WO2005013916A3 Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/pin in human cells
10/25/2007WO2004086953A3 Method for diagnosis and treatment of bone turnover
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007WO2001040300A8 Protease resistant tumor suppressor p14(arf)
10/25/2007US20070250045 Controlled release systems and methods for osteal growth
10/25/2007US20070250044 Controlled release systems and methods for intervertebral discs
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249807 Polypeptide for preventing or reducing ischemia, systemic inflammatory response
10/25/2007US20070249647 Substituted CIS- and trans-stilbenes as therapeutic agents
10/25/2007US20070249554 Methods for therapy of neurodegenerative disease of the brain
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249541 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
10/25/2007US20070249540 Methods for Inhibiting Proteasome and Heat Shock Protein 90
10/25/2007US20070249539 Vascular endothelial growth factor; hypoxia responsive element; amyotrophic lateral sclerosis
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249537 Absorption enhancing agents
10/25/2007US20070249536 Three-component polyanhydride copolymers and a method of forming the same
10/25/2007US20070249535 Methods for treating bone tumors
10/25/2007US20070249534 Novel medicament for treating neurodegenerative diseases
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249532 Modified growth hormones
10/25/2007US20070249531 Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
10/25/2007US20070249530 Bcma Polypeptides and Uses Thereof
10/25/2007US20070249529 Compositions Comprising Polypeptides
10/25/2007US20070249528 Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils
10/25/2007US20070249527 autoimmune diseases; antiarthritic agents; inflammatory bowel disorders; psoriasis; antiallergens; chronic obstructive pulmonary disease; antiallergens
10/25/2007US20070249526 Process for the preparation of cyclic peptides
10/25/2007US20070249525 Use of erythropoietin in the treatment of rheumatoid arthritis
10/25/2007US20070249524 High affinity ligands bind to clostridium difficile toxin A
10/25/2007US20070249523 Neurotherapeutic composition and method therefor
10/25/2007US20070249522 Injectable formulations containing succinate
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249520 Stable emulsion formulations
10/25/2007US20070249518 Compositions and Methods for Treating Mental Disorders
10/25/2007US20070249033 Methods of terminal sterilization of biological products
10/25/2007US20070249022 Osteoporosis; transforming growth factors; pyrogen-free
10/25/2007US20070249021 Deglycosylated and Desialidated Long Pentraxin Ptx3
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
10/25/2007US20070248996 Modulators of beta-amyloid peptide aggregation comprising D-amino acids
10/25/2007US20070248995 Molecules
10/25/2007US20070248988 Binding molecules and methods of use thereof
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248944 administering an enzyme inhibitor of c-Jun N-terminal Kinase (JNK), Anthra[1-9-cd]pyrazol-6(2H)-one for treating the vascular aneurysm
10/25/2007US20070248686 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
10/25/2007US20070248685 crosslinking gelatin with glutaraldehyde crosslinker in the presence of certain re-hydration aids, such as polyethylene glycol, polyvinylprovidone, and dextran; useful for providing hemostasis at surgical bleeding sites and traumatic bleeding site
10/25/2007US20070248676 Use of nitric oxide adducts
10/25/2007US20070248675 Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
10/25/2007US20070248674 Hydrogel Interferon Formulations
10/25/2007US20070248658 Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
10/25/2007US20070248652 Nutritional Food and Feed, Compostition, Processing and Method of Use
10/25/2007US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
10/25/2007US20070248644 Muller Stem Cells
10/25/2007US20070248641 Use of Del-1 in Hair, Bone and Cartilage Regeneration
10/25/2007US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248615 T helper cell epitopes
10/25/2007US20070248611 Methods wanted for treating unwanted weight loss or eating disorders by administering a trkb agonist
10/25/2007US20070248609 Therapeutic Method
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248607 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248595 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248587 Wet wipes including a composition for reduction and prevention of wrinkles on the skin
10/25/2007US20070248586 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
10/25/2007US20070248585 Methods of regulating renalase (Monoamime Oxidase C)
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248577 Methods and compositions for administering stem cells
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007US20070248571 Ejection Liquid, Ejection Method, Method for Forming Liquid Droplets, Liquid Ejection Cartridge and Ejection Apparatus
10/25/2007US20070248569 Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
10/25/2007US20070248567 Protein crosslinkers, crosslinking methods and applications thereof
10/25/2007US20070248548 Stable hydroalcoholic oral spray formulations and methods
10/25/2007US20070248544 Mullerian inhibiting substance levels and ovarian response